Heron Therapeutics Inc
SWB:AXD2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Heron Therapeutics Inc
SWB:AXD2
|
US |
|
E
|
Essential Utilities Inc
SWB:A2A
|
US |
|
B
|
Berkshire Hathaway Inc
F:BRH
|
US |
|
Surya Toto Indonesia Tbk PT
IDX:TOTO
|
ID |
|
A
|
Alpha Microelectronics Corp
TPEX:8024
|
TW |
|
Space Shower Skiyaki Holdings Inc
TSE:4838
|
JP |
|
E
|
Eversource Energy
F:NWJ
|
US |
|
Xlife Sciences AG
SIX:XLS
|
CH |
|
S
|
Sekisui House Ltd
DUS:SPH1
|
JP |
|
T
|
TAC Consumer PCL
SET:TACC
|
TH |
|
H
|
Hainan Strait Shipping Co Ltd
SZSE:002320
|
CN |
|
P
|
Propel Global Bhd
KLSE:PGB
|
MY |
|
RS Group PLC
OTC:EENEF
|
UK |
|
B
|
Boosh Plant Based Brands Inc
OTC:VGGIF
|
CA |
|
Umicore SA
F:NVJP
|
BE |
|
Y
|
YJN Co Ltd
TPEX:3191
|
TW |
Bankruptcy Probability
Heron Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Heron Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Heron Therapeutics Inc
NASDAQ:HRTX
|
74m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
484.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
223.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
86.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Heron Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Heron Therapeutics Inc has total debt of 142.7m USD. This includes both short-term (0 USD) and long-term (142.7m USD) debt.
You can find a full breakdown on its Balance Sheet.